We are live on ! Find out more
BLPH

Bellerophon Therapeutics, Inc.

Delisted

BLPH was delisted on the 13th of October, 2023.

Name Holding Trade Value Shares
Change
Change in
Stake
NMVA
1
New Mountain Vantage Advisers
New York
$31.5M
PCM
2
Puissance Capital Management
New York
$17.3M
VMI
3
VHCP Management II
New York
$8.63M
BC
4
Boxer Capital
California
$3.86M
Renaissance Technologies
5
Renaissance Technologies
New York
$2.15M +$224K +7,047 +11%
Vanguard Group
6
Vanguard Group
Pennsylvania
$2.04M +$509K +16,009 +32%
Fidelity Investments
7
Fidelity Investments
Massachusetts
$1.35M -$339K -10,673 -20%
EI
8
EAM Investors
California
$483K -$12.1K -379 -2%
TI
9
Telemetry Investments
New York
$414K +$254K +7,972 +151%
Bank of New York Mellon
10
Bank of New York Mellon
New York
$367K -$2.8K -88 -0.7%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$300K
BlackRock
12
BlackRock
New York
$161K +$25.3K +795 +18%
Royal Bank of Canada
13
Royal Bank of Canada
Ontario, Canada
$147K -$9.35K -294 -6%
DS
14
DRW Securities
Illinois
$146K +$148K +4,667 New
Northern Trust
15
Northern Trust
Illinois
$134K +$11.4K +357 +9%
LPL Financial
16
LPL Financial
California
$131K
Creative Planning
17
Creative Planning
Kansas
$80K
BCM
18
Bridgeway Capital Management
Texas
$48K
JP Morgan Chase
19
JP Morgan Chase
New York
$47K +$47.4K +1,491 New
LTFS
20
Ladenburg Thalmann Financial Services
Florida
$46K
Millennium Management
21
Millennium Management
New York
$36K +$36.4K +1,143 New
State Street
22
State Street
Massachusetts
$29K +$29.3K +920 New
TSS
23
Two Sigma Securities
New York
$29K +$29.6K +931 New
CIBC Private Wealth Group
24
CIBC Private Wealth Group
Georgia
$26K
UBS Group
25
UBS Group
Switzerland
$13K +$13.1K +411 New